VALUExBRK 2025: Get The Insights From all This Years Speakers

VALUExBRK 2025 is a value investing event hosted by Guy Spier and the Aquamarine team, held in Omaha in May of 2025. The gathering brings together leading investors and thinkers ahead of the Berkshire Hathaway Annual Shareholders Meeting, featuring a diverse lineup of speakers from the investment and business world. VALUExBRK serves as a platform for sharing investment insights, networking, and discussing current trends in business and finance among a global audience.

The speaker lineup includes notable investors and thought leaders such as Chris Davis, William Green, Chris Begg, Renato Gueraldi, Luca Dellanna, Ardal Loh-Gronager, Robert Hagstrom, Monsoon Pabrai, Michael Green, Chris Bloomstran, Brett Gardner, Joachim Grube-Nagel, and Mohnish Pabrai.

Especially the Chis Davis, Chris Begg and Luca Dellanna talks are inspiring, and they usually stay away from public presentations.

Share the news

Disclaimer of liability

The above has been prepared by Børsgade ApS for information purposes and cannot be regarded as a solicitation or recommendation to buy or sell any security. Nor can the information etc. be regarded as recommendations or advice of a legal, accounting or tax nature. Børsgade cannot be held liable for losses caused by customers’/users’ actions – or lack thereof – based on the information in the above. We have made every effort to ensure that the information in the above is complete and accurate, but cannot guarantee this and accept no liability for errors or omissions.

Readers are advised that investing may involve a risk of loss that cannot be determined in advance, and that past performance and price development cannot be used as a reliable indicator of future performance and price development. For further information please contact info@borsgade.dk

You might also find this interesting:

Warren Buffett: Lessons from the Oracle of Omaha

In this special celebratory episode from The Investor’s Podcast, host William Green shares his personal observations from attending the annual shareholder meeting in Omaha where the announcement was made, describing it as the most joyful meeting he’s ever attended.

The episode features powerful highlights from Green’s previous conversations with legendary investors including Joel Greenblatt, Nick Sleep, Thomas Russo, Chris Davis, Chuck Akre, and Christopher Bloomstran, all discussing Buffett’s profound influence on their investment approaches.

Chris Davis: Navigating Todays Turbulent Markets With Bill Miller

Two legendary portfolio managers, Chris Davis and Bill Miller, engaged in a comprehensive discussion about navigating today’s volatile investment landscape, drawing from their combined decades of experience managing billions in assets.

The conversation, structured around nine key topics, covers everything from investment temperament and market volatility to emerging technologies and geopolitical challenges. Miller, famous for outperforming the S&P 500 for 15 consecutive years while managing the Legg Mason Value Trust, and Davis share insights on stewardship, patience, and contrarian investing approaches. The discussion emphasizes the importance of long-term thinking, adaptability, and maintaining perspective during uncertain times.

Michael Mauboussin: Drawdowns Are The Unavoidable Cost of Long-Term Investing

Michael Mauboussin from Morgan Stanley Investment Management have published a comprehensive analysis examining stock market drawdowns and recovery patterns from 1985 to 2024. The research reveals that even the most successful investments experience severe price declines, with the median stock suffering an 85% drawdown that takes 2.5 years from peak to trough.

The study analyzed over 6,500 companies and found that more than half never recover to their previous highs. Michael’s work demonstrates that large drawdowns are an inevitable feature of equity investing, affecting individual stocks, mutual funds, and even portfolios with perfect foresight.

Thomas Gayner: My Current Take on Novo Nordisk

In his interview, Tom Gayner, CEO of Markel Group, reflects on investment principles shaped by Warren Buffett and Charlie Munger, and offers a detailed assessment of Novo Nordisk. Gayner praises Novo Nordisk for its business quality, global leadership in diabetes treatment, and strong growth trajectory. He credits the company’s disciplined management and innovation in pharmaceuticals as exemplary, aligning with his own standards of long-term value creation.